Scientific collaboration with Biogen

December 10, 2019

Ad Scientiam and Biogen announce a scientific collaboration aimed at developing innovative digital solutions for clinical research in neuroscience. This collaboration builds on Ad Scientiam's successful experience with MSCopilot®, its software medical device, and Biogen's commitment to innovative scientific research to defeat devastating neurological diseases.

Share

MSCopilot®: New clinical results confirm central role of digital biomarkers in the monitoring of patients with multiple sclerosis Our news
en_USEnglish